Dialysis industry news

Stories from the dialysis comunity across the globe.



Dialysis patient pushes for Lincoln County, WV EMS Levy - WOWK PDF Print

83-year-old Dot McClure has been on dialysis since December and relies on Lincoln County EMS employees to get her to her treatments every week.


"It's very important to me because I have to go three times a week or I wouldn't be here." said Dot.


Since the EMS and fire levies didn't pass in November, services like Dot's weekly pick-ups are in peril. Lincoln County, WV will be holding a special election on February 28th to give voters another chance to make their decision. 


"We know that there will be cuts if we don't get that money, we just aren't sure to which departments." said Paul McCallister with Lincoln County EMS.


Every year the levy provides 20% of overall funding to emergency personnel and that money is used for payroll purposes only. April Roach, an EMT-B for Lincoln, says she has dedicated a large part of her life to her profession.

"I'm always constantly thinking about that next call and how I'm going to handle that, and how I can provide the best service to that person at that time." said April.

Neither levy would result in an increase in taxes for citizens, but emergency personnel think that wasn't communicated well enough the last time around. 


"Property taxes increased this year in the county dramatically and I think people figured they are taxed enough." said Paul McCallister. 

Dot hopes that her EMS family will continue to be able to stay by her side.


"That's the reason everyone I know I tell them to get out and vote for that levy...cause we need it." said Dot.


Poll will be open across Lincoln County, WV from 6:30 A.M. to 7:30 P.M. on February 28th. 

...

 
Dialysis centre at Fort hospital - The Hindu PDF Print

A dialysis centre will be set up soon at Government Hospital, Fort, here. An X-ray unit too will be set up at the hospital, Health Minister V.S. Sivakumar has said.

He was speaking after inaugurating the Kerala Health Research and Welfare Society (KHRWS) pay wards at the hospital on Thursday. There are 14 rooms in the two-storey pay ward complex, which measures 4,304 sq ft. Mr. Sivakumar said the dialysis unit, with five beds, would be set up in this complex.

At Panchakarma centre

A 40-room KHRWS pay ward would soon be set up at the Panchakarma treatment centre at Poojappura, Mr. Sivakumar said. He was speaking after inaugurating a workshop on medicinal plants organised by the hospital here on Thursday.

Mr. Sivakumar said the pay ward would be set up at a cost of Rs.3 crore. It would have six VIP suites and 32 deluxe rooms. The foundation stone for the complex would be laid on March 4.

'; if (google_ads[0].type == "image") { s += 'image'; } else if (google_ads[0].type == "flash") { s += ''; } else if (google_ads[0].type == "html") { s += google_ads[0].snippet; } else if (google_ads[0].type == "text") { // Adjust text sizes to occupy the majority of ad space. if (google_ads.length == 1) { ad_title_class = 'ad_below_title_large'; ad_text_class = 'ad_below_text_large'; ad_url_class = 'ad_below_url_large'; } else { ad_title_class = 'ad_below_title'; ad_text_class = 'ad_below_text'; ad_url_class = 'ad_below_url'; } for(var i=0; i ' + google_ads[i].line1 + '
' + google_ads[i].line2 + ' ' + google_ads[i].line3 + '
' + '' + google_ads[i].visible_url + '

...

 
Urinary adiponectin predicts diabetic nephropathy progression in type 1 diabetes - Healio PDF Print

Urinary adiponectin strongly and independently predicted the progression of diabetic nephropathy from macroalbuminuria to end-stage renal disease in patients with type 1 diabetes, according to research published in Diabetes Care.

The findings on urinary adiponectin (uADP) provide added predictive benefit to current biomarkers including albumin excretion rates (AER) and estimated glomerular filtration rates, according to researchers.  

“From a clinical point of view, these results are important because the risk of progression to end-stage renal disease in patients with type 1 diabetes is not easy to assess based on either AER or eGFR given each measure’s limitations,” the researchers wrote.

Nicolae M. Panduru, MD, MSc, PhD,of the Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, and colleagues measured uADP in 2,090 patients with type 1 diabetes followed for an average of 5.8 years and in 111 individuals without diabetes.

The researchers defined progression as a change in albuminuria, based on AER, to a higher stage or development of ESRD. Various Cox regression and competing risk models were utilized to assess the predictive value of uADP for diabetic nephropathy progression.

The investigators estimated the predictive benefit added to AER or eGFR based on area under the receiver operating characteristic curve, integrated discrimination improvement, ongoing net reclassification improvement and other statistical indexes. Multiple regression analyses were used to investigate uADP determinants.

Progression to ESRD was independently predicted by uADP (HR = 1.6; P < .001) with capability greater than AER (P= .04) and as good as eGFR (P = .79).

Further, uADP added significant predictive value when used with AER based on integrated discrimination improvement (0.115; P < .0001) and net reclassification improvement (0.794; P = .03). The same was seen when used with eGFR based on integrated discrimination improvement (0.087; P < .0001) and net reclassification improvement (0.637; P< .001).

Glycemic control, tubular injury and AER were common determinants of uADP.

“In patients with type 1 diabetes and macroalbuminuria, uADP not only is a strong independent predictor for diabetic nephropathy progression to ESRD, but also adds significant predictive benefit when used together with either AER or eGFR,” the researchers wrote. “This may be due to uADP capturing recognized risk factors for diabetic nephropathy progression such as glomerular damage, tubular dysfunction, and glycemic control as well as other factors important for diabetic nephropathy progression like cachexia.” – by Allegra Tiver

Disclosure: Analyses and assays were partly sponsored by Roche Diagnostics. Please see study for full list of researchers’ relevant financial disclosures.

...

 
New Souris dialysis unit set to open mid-March - CBC.ca PDF Print
P.E.I. Health Minister Doug Currie

Health and Wellness Minister Doug Currie says the new Souris dialysis facility is modern and state-of-the-art. (CBC)

A new $300,000 dialysis unit will be installed at the Souris Hospital by mid-March, says Health and Wellness Minister Doug Currie.

The community hasn't had dialysis services since July 2014 when it was discovered the water filtration system wasn't up to standards.              

Patients have been bused to Charlottetown for treatment ever since.

The installation means six patients will resume receiving their dialysis in Souris.

"It's been a bit of a domino effect. So now, with the opening of this facility, it is an impact [on] all patients across the province. So, certainly pleased," said Currie.

"Certainly want to acknowledge that in Souris we have a modern, state-of-the-art, expanded unit and facility for this community."

The unit will offer more privacy, improved infection control and better nursing work areas, says Currie.

It will be supported by four nursing staff.

Other dialysis units in P.E.I. are located in Alberton, Charlottetown and Summerside.

Government funding for dialysis services has increased from $2.7 million in 2007 to $6 million in 2014-2015.

...

 
Kidney Community Lauds Bi-Partisan, Bicameral Legislation to Improve Care ... - Virtual Press Office (press release) PDF Print

WASHINGTON, Feb. 27, 2015 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP) today praised the bicameral introduction of "The Chronic Kidney Disease Improvement in Research and Treatment Act" (H.R. 1130, S. 598), a bipartisan bill that elevates care, expands access, and promotes research to benefit more than 636,000 Americans living with kidney failure, which is known as end-stage renal disease (ESRD). KCP is a broad-based coalition of patient advocates, clinicians, care professionals, dialysis providers, researchers and manufacturers working together to improve quality of care for individuals with chronic kidney disease (CKD) and ESRD.

Currently, 31 million Americans have some form of kidney disease and are at risk of developing kidney failure absent some form of disease management education or preventive care. Each year, more than 100,000 Americans are diagnosed with ESRD – the final stage of CKD – and therefore require a kidney transplant or dialysis. Due to the limited number of kidneys available for transplantation, 430,000 Americans now rely on life-sustaining dialysis care to survive. In general, patients must undergo dialysis three times a week for several hours per treatment. Under current law, dialysis treatments are covered by the Medicare program, regardless of the individual's age.

Advocates have long stressed that federal policies are needed to provide patient choice and to ensure access to life-sustaining dialysis, to increase research into CKD, and to create stability in Medicare's crucial ESRD program. Ultimately, the legislation introduced by Representatives Tom Marino (R-PA), John Lewis (D-GA) and Peter Roskam (R-IL) in the House and Senators Ben Cardin (D-MD), Mike Crapo (R-ID) and Bill Nelson (D-FL) in the Senate would improve patient outcomes through care coordination, expand access to traditionally underserved patient populations, and set the U.S. on the path towards a cure through efficiently managed and coordinated biomedical research.

"This bill is absolutely vital as it provides a clear blueprint for the future of the ESRD program" said Dr. Ed Jones, Chairman of Kidney Care Partners and a practicing nephrologist. "By supporting care coordination, greater patient choice, coordinated research programs, and economic stability, this legislation would strengthen the delivery of care for millions of Americans living with kidney disease."

Specifically, The Chronic Kidney Disease Improvement in Research and Treatment Act would:

(1) Improve the coordination of care: The legislation would expand care options for patients by, among other things, allowing individuals diagnosed with kidney failure to enroll in the Medicare Advantage program. Under current law, individuals who develop kidney failure are not permitted to enroll in Medicare Advantage (MA) plans despite the Medicare Payment Advisory Commission's recommendation to eliminate the restriction in order to provide ESRD beneficiaries with the same freedom of choice and access to improved coordinated services as other Medicare-enrolled individuals. Therefore, the legislation would allow ESRD patients to enroll in – and reap the benefits of – MA plans. The bill also would reauthorize on a permanent basis the Special Needs Plan (SNP) for patients with kidney failure who need additional care attention, as well as extend the length of time beneficiaries may choose to maintain their existing insurance coverage. Importantly, the legislation looks to the future by establishing a voluntary coordinated care program. The coordinated care program would allow physicians and dialysis facilities to work together to improve the coordination of care and reduce costly hospitalizations and rehospitalizations.

(2) Promote patient access and choice:The legislation would expand patient access to kidney disease education programs and home dialysis treatment options through telemedicine, as well as create incentives for nephrologists and other dialysis health care professionals to work in underserved rural or urban areas. The bills also would establish renal dialysis facilities as a cost-effective alternative to hospital outpatient departments for individuals diagnosed with acute kidney injury.

(3) Expand research and enhance coordination:The legislation would identify gaps in research and improve the coordination of federal research efforts. Specifically, the bills would require the GAO to assess the adequacy of federal funding for CKD research relative to the expenditures for CKD care and identify gaps in research. Additionally, the bills would require improved coordination among the various federal agencies conducting CKD research by requiring the development of a strategic plan. Third, the bills would require the Secretary to conduct a study to better understand the progression of kidney disease and treatment of kidney failure in minority populations.

"The kidney community applauds Representatives Marino, Lewis and Roskam as well as Senators Cardin, Crapo and Nelson for their long-time leadership and ongoing efforts to protect this important and vulnerable patient population, and we look forward to working with lawmakers to advance legislation that will improve patient choice and outcomes," added Dr. Jones. "The Chronic Kidney Disease Improvement in Research and Treatment Act ensures that individuals with kidney disease, have the tools, resources, and care they need to live their lives to the fullest today and into the future."

About Kidney Care Partners
KCP is an alliance of patient advocates, nephrologists, healthcare professionals, dialysis providers and manufacturers dedicated to working together to improve quality of care for individuals with chronic kidney disease (CKD) and end-stage renal disease (ESRD). To learn more about Kidney Care Partners, visitkidneycarepartners.org.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kidney-community-lauds-bi-partisan-bicameral-legislation-to-improve-care-coordination-expand-choice-and-enhance-research-for-millions-with-kidney-disease-kidney-failure-300042867.html

SOURCE Kidney Care Partners

...

 
<< Start < Prev 391 392 393 394 395 396 397 398 399 400 Next > End >>

Page 391 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.